Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-07

FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals LLC's original application for a generic sodium nitroprusside product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium nitroprusside (sodium nitroprusside)

Snippet

ORIG AP for SODIUM NITROPRUSSIDE (SODIUM NITROPRUSSIDE)